Chandreyee Gupta

Chandreyee Gupta

Chandreyee is a Senior Consultant and Group Lead in the Health Economics and Outcomes Research (HEOR) Evidence Synthesis team for the Neuroscience and Pain portfolio at Eli Lilly and Company in India. In this role, she manages the team’s evidence synthesis initiatives supporting both early and late-stage pharmaceutical assets, working in close collaboration with multidisciplinary and international stakeholders. Her team conducts scientific projects focused on generating robust and methodologically sound evidence to support the internal portfolio strategy of targeted indications as well as the market access, reimbursement, and global health technology assessment (HTA) submissions. She also serves as an independent scientific lead for business-critical projects, with accountability for the scientific direction and delivery of key evidence outputs. She is a trained microbiologist and public health researcher with approximately 10 years of experience in health research across multiple domains, including six years of experience within the pharmaceutical industry, with a focus on HEOR. She holds a Master’s degree (MPH) and an MPhil, both with an academic focus on epidemiology, which provides the methodological foundation for her work in population-level evidence generation, outcomes research, and health policy-relevant analyses.